Munich Re - Q1 2026 Earnings Analysis

Performance Highlights

Munich Re reported a Q1 2026 net result of €1,714m, fractionally below the analyst consensus of €1,729m, while the operating result of €2,230m came in €123m short of expectations — driven largely by weaker-than-forecast life and health reinsurance and ERGO International operating contributions. Group insurance revenue fell 5% year-on-year to €15,018m, primarily reflecting adverse currency translation of –€767m and deliberate volume reductions in P&C renewals, though the total technical result surged to €2,676m from €2,054m in Q1 2025.

The standout driver was exceptionally low major-loss activity in P&C reinsurance, where the combined ratio of 66.8% crushed the consensus estimate of 74.6%; major losses totalled just €130m or 3.5% of net insurance revenue versus an 18% annual expectation, as nat cat losses fell to €55m compared with €757m during the LA wildfires-affected Q1 2025. Global Specialty Insurance also outperformed at an 83.7% combined ratio versus consensus of 89.2%, while ERGO Germany delivered a total technical result of €425m against a €378m consensus. Return on equity reached an annualised 19.7%, and the Solvency II ratio remained robust at 292%.

Management Outlook and Forward Catalysts

Management reaffirmed full-year 2026 guidance of €6.3bn net result, alongside targets of approximately €64bn group insurance revenue, a reinsurance combined ratio of approximately 80%, and return on investment above 3.5%, signalling confidence that Q1's operating momentum is sustainable even as the reinsurance revenue target of approximately €40bn faces incremental pressure from currency headwinds and April renewal volume reductions. The reinvestment yield of 4.2% and an expected Q2 catch-up in regular income from inflation-linked bonds and private equity distributions provide near-term investment support.

The central investor debate centres on whether the normalised P&C combined ratio, guided at approximately 80%, can be held as pricing softens — CFO Andrew Buchanan acknowledged the distribution of outcomes is now asymmetric, with upside to 80% more likely than downside. Bulls will focus on the healthy deal pipeline in L&H reinsurance, sustained discounting benefits above 9%, and disciplined cycle management preserving portfolio quality; bears will watch the 18% major-loss budget, further risk-adjusted price declines in July renewals where nat cat business represents approximately 35% of volume, and the loss component build-up of 1.1 percentage points that signals prudent but structurally lower new-year profitability recognition.